FDA approves Epclusa for treatment of chronic Hepatitis C virus infection - FDA.gov

Reuters UK

FDA approves Epclusa for treatment of chronic Hepatitis C virus infection FDA.gov The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients with moderate to severe cirrhosis (decompensated cirrhosis ... Gilead Gets FDA Approval for Combo Hepatitis C DrugWall Street Journal US FDA approves Gilead's hep C drug EpclusaReuters FDA Approves Gilead''s Epclusa To Treat Genotypes Of Chronic Hepatitis CNasdaq Seeking Alpha all 7 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNHr8AexoJnCGuFqP1qU6VULSkoZ6w&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779142974693&ei=s5VyV9DVPNPRpwe-xbvIBg&url=http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm508915.htm
via IFTTT